These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8460869)

  • 21. Tamoxifen: toxicities and drug resistance during the treatment and prevention of breast cancer.
    Jordan VC
    Annu Rev Pharmacol Toxicol; 1995; 35():195-211. PubMed ID: 7598491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Jordan VC; Morrow M
    J Natl Cancer Inst; 2003 May; 95(9):683-4; author reply 684-5. PubMed ID: 12734320
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast cancer drug shows promise for some survivors.
    Levenson D
    Rep Med Guidel Outcomes Res; 2003 Oct; 14(21):7-9. PubMed ID: 14628765
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term tamoxifen trial halted.
    Marshall E
    Science; 1995 Dec; 270(5242):1562. PubMed ID: 7502061
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen in advanced male breast cancer.
    Aisner J; Ross DD; Wiernik PH
    Arch Intern Med; 1979 Apr; 139(4):480-1. PubMed ID: 435005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.
    Du XL
    J Natl Cancer Inst; 2003 May; 95(9):683; author reply 684-5. PubMed ID: 12734321
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer face-off.
    Brink S
    US News World Rep; 2002 Jun; 132(19):54. PubMed ID: 12066455
    [No Abstract]   [Full Text] [Related]  

  • 29. Tamoxifen in the management of advanced breast carcinoma in Nigerian women.
    Senbanjo RO; Ihekwaba FN; Ajayi OO
    West Afr J Med; 1990; 9(1):44-9. PubMed ID: 1702986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen and breast cancer--from palliation to prevention.
    Rich SE
    Cancer Nurs; 1993 Oct; 16(5):341-6. PubMed ID: 7505194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen and breast cancer: indications and response.
    Hughes R; Kirollos M
    Practitioner; 1989 Jun; 233(1470):810, 813, 815. PubMed ID: 2594634
    [No Abstract]   [Full Text] [Related]  

  • 32. Drugs for the gynecologist to prescribe in the prevention of breast cancer: current status and future trends.
    Goldstein SR
    Am J Obstet Gynecol; 2000 May; 182(5):1121-6. PubMed ID: 10819845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of tamoxifen.
    Robert NJ
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):15-20. PubMed ID: 9065922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen for the reduction in the incidence of breast cancer in women at high risk for breast cancer.
    Honig SF
    Ann N Y Acad Sci; 2001 Dec; 949():345-8. PubMed ID: 11795374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen in the treatment of stage II breast cancer. Clinical experience at Siriraj Hospital.
    Tepmongkol P; Suphaphongs N; Chantarakul N; Thansakul A
    J Med Assoc Thai; 1984 Dec; 67(12):670-6. PubMed ID: 6533227
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis.
    Hershman D; Sundararajan V; Jacobson JS; Heitjan DF; Neugut AI; Grann VR
    J Clin Oncol; 2002 Jan; 20(1):9-16. PubMed ID: 11773148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen approved for premenopausal women with advanced breast cancer.
    Oncology (Williston Park); 1989 Jun; 3(6):44. PubMed ID: 2641502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.